
01/04/2025
We are seeing outstanding results with our patients! Sleep, TMS & Wellness Center offers Spravato treatments to help alleviate treatment-resistant depression.
Spravato (esketamine) is a prescription nasal spray designed for individuals with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or behaviors. Derived from ketamine, an anesthetic known for its rapid-acting antidepressant effects, Spravato provides a new approach to treatment.
Why Choose Spravato?
-Effective for Treatment-Resistant Depression (TRD): Ideal for patients who haven’t improved after trying at least two traditional antidepressants.
Rapid Symptom Relief:
-Unlike conventional antidepressants that take weeks to work, Spravato has been shown to reduce depressive symptoms within hours to days.
Supports Patients with Suicidal Ideation:
-One of the few medications approved for MDD with suicidal thoughts, offering fast relief for those in crisis.
A Unique Mechanism of Action:
-While traditional antidepressants target serotonin, norepinephrine, or dopamine, Spravato acts on the NMDA receptor, influencing glutamate levels to promote new neural connections and enhance mood.
How is Spravato Administered?
-Given under medical supervision in a healthcare setting due to potential side effects like dissociation and sedation.
-Typically taken twice a week for the first four weeks, with the frequency gradually decreasing over time.
Schedule an evaluation today! Visit dragupta.com or call 516-684-9535 to book your appointment.